Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willem Jan Meerding

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Spine|April 7, 2007
Effectiveness of a back pain prevention program: a cluster randomized controlled trial in an occupational settingHelma IJzelenberg, Willem-Jan Meerding, Alex Burdorf
Scandinavian Journal of Work, Environment & Health|November 9, 2005
Reduced productivity after sickness absence due to musculoskeletal disorders and its relation to health outcomesFreek Lötters, Willem-Jan Meerding, Alex Burdorf
European Journal of Public Health|February 16, 2006
Incidence and costs of injuries in The NetherlandsWillem Jan Meerding, Saakje Mulder, Ed F van Beeck
Pharmacoeconomics|August 16, 2005
Societal discounting of health effects in cost-effectiveness analyses: the influence of life expectancySuzanne Polinder, Willem Jan Meerding, Job van Exel, et al.
Bulletin of the World Health Organization|January 24, 2007
Assessing the burden of injury in six European countriesSuzanne Polinder, Willem Jan Meerding, Saakje Mulder, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 22, 2012
Antihypertensive drugs: a perspective on pharmaceutical price erosion and its impact on cost-effectivenessRodrigo Refoios Camejo, Clare McGrath, Ron Herings, et al.
Health Policy (Amsterdam, Netherlands)|October 14, 2020
Who contextualises clinical epidemiological evidence? A political analysis of the problem of evidence-based medicine in the layered Dutch healthcare systemMartijn Felder, Hester van de Bovenkamp, Willem Jan Meerding, et al.
European Journal of Public Health|April 24, 2002
Age-specific increases in health care costsJohan J Polder, Luc Bonneux, Willem Jan Meerding, et al.
Pharmacoeconomics|April 20, 2005
The relationship between productivity and health-related QOL: an explorationWerner B F Brouwer, Willem-Jan Meerding, Leida M Lamers, et al.
Pharmacoeconomics|February 8, 2005
Measuring productivity changes in economic evaluation: setting the research agendaMarc Koopmanschap, Alex Burdorf, Karin Jacob, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Spine|April 7, 2007
Effectiveness of a back pain prevention program: a cluster randomized controlled trial in an occupational settingHelma IJzelenberg, Willem-Jan Meerding, Alex Burdorf
Scandinavian Journal of Work, Environment & Health|November 9, 2005
Reduced productivity after sickness absence due to musculoskeletal disorders and its relation to health outcomesFreek Lötters, Willem-Jan Meerding, Alex Burdorf
European Journal of Public Health|February 16, 2006
Incidence and costs of injuries in The NetherlandsWillem Jan Meerding, Saakje Mulder, Ed F van Beeck
Pharmacoeconomics|August 16, 2005
Societal discounting of health effects in cost-effectiveness analyses: the influence of life expectancySuzanne Polinder, Willem Jan Meerding, Job van Exel, et al.
Bulletin of the World Health Organization|January 24, 2007
Assessing the burden of injury in six European countriesSuzanne Polinder, Willem Jan Meerding, Saakje Mulder, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 22, 2012
Antihypertensive drugs: a perspective on pharmaceutical price erosion and its impact on cost-effectivenessRodrigo Refoios Camejo, Clare McGrath, Ron Herings, et al.
Health Policy (Amsterdam, Netherlands)|October 14, 2020
Who contextualises clinical epidemiological evidence? A political analysis of the problem of evidence-based medicine in the layered Dutch healthcare systemMartijn Felder, Hester van de Bovenkamp, Willem Jan Meerding, et al.
European Journal of Public Health|April 24, 2002
Age-specific increases in health care costsJohan J Polder, Luc Bonneux, Willem Jan Meerding, et al.
Pharmacoeconomics|April 20, 2005
The relationship between productivity and health-related QOL: an explorationWerner B F Brouwer, Willem-Jan Meerding, Leida M Lamers, et al.
Pharmacoeconomics|February 8, 2005
Measuring productivity changes in economic evaluation: setting the research agendaMarc Koopmanschap, Alex Burdorf, Karin Jacob, et al.
Pageof 4